Introduction: Coping occurs when health system personnel must make additional, often undocumented efforts to compensate for existing system and management deficiencies. While such efforts may be done with good intentions, few studies evaluate the broader impact of coping.

Methods: We developed a computational simulation model of Bihar, India's routine immunisation supply chain where coping (ie, making additional vaccine shipments above stated policy) occurs. We simulated the impact of coping by allowing extra trips to occur as needed up to one time per day and then limiting coping to two times per week and three times per month before completely eliminating coping.

Results: Coping as needed resulted in 3754 extra vaccine shipments over stated policy resulting in 56% total vaccine availability and INR 2.52 logistics cost per dose administered. Limiting vaccine shipments to two times per week reduced shipments by 1224 trips, resulting in a 7% vaccine availability decrease to 49% and an 8% logistics cost per dose administered increase to INR 2.73. Limiting shipments to three times per month reduced vaccine shipments by 2635 trips, which decreased vaccine availability by 19% to 37% and increased logistics costs per dose administered by 34% to INR 3.38. Completely eliminating coping further reduced shipments by 1119 trips, decreasing total vaccine availability an additional 24% to 13% and increasing logistics cost per dose administered by 169% to INR 9.08.

Conclusion: Our results show how coping can hide major system design deficiencies and how restricting coping can improve problem diagnosis and potentially lead to enhanced system design.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747917PMC
http://dx.doi.org/10.1136/bmjgh-2019-001609DOI Listing

Publication Analysis

Top Keywords

vaccine shipments
16
vaccine availability
16
dose administered
16
logistics cost
12
cost dose
12
coping
9
coping hide
8
routine immunisation
8
immunisation supply
8
supply chain
8

Similar Publications

Article Synopsis
  • Early disparities in COVID-19 vaccination rates among racial groups have often been attributed to individual attitudes towards vaccines, but there may be deeper issues related to how vaccines were distributed.
  • A study analyzed shipping data for over 385,000 doses in Pennsylvania's initial vaccine rollout and found that predominantly White neighborhoods received 81.4% more vaccine doses than Black neighborhoods.
  • The results suggest that the distribution practices of pharmacy chains, rather than state or federal decisions, contributed significantly to this inequitable access, highlighting the need for regulation and monitoring of how public health resources are allocated.
View Article and Find Full Text PDF

Controlled manufacturing and long-term stability are key challenges in the development and translation of nanomedicines. This is exemplified by the mRNA-nanoparticle vaccines against COVID-19, which require (ultra-)cold temperatures for storage and shipment. Various cryogenic protocols have been explored to prolong nanomedicine shelf-life.

View Article and Find Full Text PDF

The Government of India, in collaboration with the World Health Organization (WHO), established the National Polio Surveillance Project (NPSP) in 1997 and initiated acute flaccid paralysis (AFP) surveillance to achieve the goal of polio eradication. The WHO South-East Asia Region, comprising of 11 countries, including India, was certified as polio-free in March 2014. India was also validated to have eliminated maternal and neonatal tetanus in May 2015.

View Article and Find Full Text PDF
Article Synopsis
  • Uganda's yellow fever (YF) surveillance system monitored outbreaks from 2017-2022 at seven high-risk sites, assessing attributes like timeliness and data completeness.
  • A total of 3,073 suspected and 15 confirmed YF cases were reported, with significant delays in case confirmation noted (37 days median lag) and varying completeness (76% external, 65% internal).
  • Stakeholders found the system simple and acceptable, contributing to detecting 71% of previous outbreak cases and guiding vaccination efforts, but issues with delays and incomplete data limited its overall efficacy.
View Article and Find Full Text PDF

SARS-CoV-2 serological testing is useful to determine seroprevalence, epidemiological trends, and the extent of transmission. The collection and transport of serum samples can be logistically challenging, especially in remote underserved areas. Dried blood spots (DBSs) would allow easier sample collection and logistical handling compared with standard serum collection, particularly for extensive and repeated SARS-CoV-2 serosurveys.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!